Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (Processa or the Company), a clinical-stage pharmaceutical company focused on ...

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying ...

Alterity Therapeutics ATHE shares rose 97.2% to $5.74 during Thursday's pre-market session. The company's market cap stands at $50.1 million. NanoVibronix NAOV shares ros ...

David Young, the President of Research & Development at Processa Pharmaceuticals , Inc. (NASDAQ:PCSA), has increased his ...

根据 InvestingPro 的数据，Processa Pharmaceuticals, Inc. (NASDAQ: PCSA )的首席执行官George ...

已保存。查看收藏列表。 Processa Pharmaceuticals, Inc.（纳斯达克股票代码：PCSA）的首席商务和战略官Patrick ...

Processa Pharmaceuticals (PCSA) announced the pricing of its “reasonable best efforts” public offering with participation from the Company’s ...

Processa Pharmaceuticals Inc. (PCSA) stock has tumbled to a 52-week low, touching down at $0.65, with InvestingPro data ...

The past two years have been punishing for the biotech and pharma space. As Wall Street chased the artificial-intelligence boom, drugmakers were left behind, with pharma stocks trading at a ...

Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Get Free Report)’s share price dropped 0.6% on Thursday .The stock traded as low as $0.80 and last traded at $0.87. Approximately 82,238 shares ...